Authors
Jan Michael Hähner, Kai-Henrik Peiffer, Michael Praktiknjo, Frank Erhard Uschner, Jonel Trebicka, Martin Sebastian McCoy
Published in
Expert review of gastroenterology & hepatology. Nov 11, 2026. Epub Nov 11, 2026.
Abstract
Progression of liver cirrhosis is a dynamic transition toward decompensation driven by portal hypertension (PH), while systemic inflammation (SI) mediates organ dysfunction and failure, acute-on-chronic liver failure (ACLF), and short-term mortality. The recent publication of the Baveno VIII consensus and of harmonized organ failure definitions calls for a reassessment of current concepts and recommendations.
PubMed/MEDLINE and Web of Science were searched from April 2026 to September 2026 for consensus documents, randomized trials, and large cohort studies on cirrhosis and its complications. Earlier landmark studies were included when they underpinned current recommendations, without any claim to completeness. Noninvasive risk stratification in compensated advanced chronic liver disease, prevention of first decompensation, the clinical phenotypes of decompensation, management of variceal bleeding including preemptive TIPS, ascites, hepatic encephalopathy, renal dysfunction, and ACLF are included together with practical guidance for triage and transfer to expert and transplant centers.
Management is shifting from reactive treatment of individual complications toward mechanism-based, preemptive care guided by dynamic risk assessment. Harmonized ACLF definitions and biomarkers of systemic inflammation should now enable trials of disease-modifying therapy, the field's largest unmet need.
PMID:
43014802
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0